TSX:ACB • CA05156X8504
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AURORA CANNABIS INC (ACB.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-11 | CIBC Capital Markets | Maintains | Neutral |
| 2022-11-11 | STA Research | Maintains | Buy |
| 2022-10-28 | STA Research | Reiterate | Buy |
| 2022-10-14 | STA Research | Maintains | Buy |
| 2022-10-07 | Morningstar Inc. | Upgrade | Buy |
| 2022-09-28 | Jefferies Financial LLC | Downgrade | |
| 2022-09-22 | Stifel Nicolaus Research | Downgrade | |
| 2022-09-22 | ATB Capital | Upgrade | Sector Perform |
| 2022-09-21 | Canaccord Capital | Downgrade | Hold |
| 2022-09-21 | CIBC Capital Markets | Downgrade | Neutral |
| 2022-09-21 | Piper Sandler | Downgrade | Neutral |
| 2022-09-16 | CIBC Capital Markets | Downgrade | Neutral |
| 2022-09-16 | STA Research | Reiterate | Buy |
| 2022-08-23 | STA Research | Reiterate | Buy |
| 2022-07-19 | Cowen | Upgrade | |
| 2022-06-24 | STA Research | Maintains | Buy |
| 2022-06-06 | Stifel Nicolaus Research | Upgrade | Hold |
| 2022-06-06 | STA Research | Downgrade | Buy |
| 2022-05-17 | Cowen | Downgrade | |
| 2022-05-13 | Cantor Fitzgerald Securities | Initiate | Hold |
| 2022-05-13 | CIBC Capital Markets | Downgrade | Neutral |
| 2022-05-13 | MKM Partners | Reiterate | Hold |
| 2022-05-13 | Piper Sandler | Downgrade | Hold |
| 2022-05-10 | ATB Capital | Downgrade | Underperform |
| 2022-05-02 | Stifel Nicolaus Research | Downgrade | Sell |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 221.339M -9.75% | 269.637M 21.82% | 343.293M 27.32% | 366.93M 6.89% | 357.11M -2.68% | 406.17M 13.74% | 351.48M -13.46% | 377.88M 7.51% | 406.89M 7.68% | 438.5M 7.77% | |
| EBITDA YoY % growth | -251.771M 12.63% | -141.588M 43.76% | -144.431M -2.01% | 57.486M 139.80% | 60.465M 5.18% | 72.013M 19.10% | 58.813M -18.33% | 72.916M 23.98% | 89.72M 23.05% | 110.12M 22.74% | |
| EBIT YoY % growth | -345.431M 10.56% | -174.363M 49.52% | -166.978M 4.24% | -25.105M 84.96% | 8.616M 134.32% | 55.045M 538.87% | 95.779M 74.00% | 108.86M 13.66% | 122.53M 12.56% | N/A | |
| Operating Margin | -156.06% | -64.67% | -48.64% | -6.84% | 2.41% | 13.55% | 27.25% | 28.81% | 30.11% | N/A | |
| EPS YoY % growth | N/A 87.80% | -0.82 -29.90% | 0.05 106.11% | -0.74 -1,574.60% | 0.34 146.58% | 0.19 -45.59% | 1.51 709.08% | 1.75 15.64% | 2.00 14.29% | N/A |
All data in CAD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 88.52% | 0.03 112.47% | 0.23 201.00% | 0.36 1,112.00% | 0.31 720.00% |
| Revenue Q2Q % growth | 82.046M -9.38% | 88.7M -9.51% | 100.75M 11.49% | 101.45M 7.71% | 109.48M 33.44% |
| EBITDA Q2Q % growth | 13.756M 151.97% | 12.12M 128.63% | 14.797M 134.21% | 21.008M 223.71% | 21.16M 53.82% |
| EBIT Q2Q % growth | -6.715M 86.30% | 160.257K 100.33% | 14.14M 125.40% | 21.21M 159.26% | 18.18M 370.74% |
All data in CAD
10 analysts have analysed ACB.CA and the average price target is 7.17 CAD. This implies a price increase of 43.6% is expected in the next year compared to the current price of 4.99.
AURORA CANNABIS INC (ACB.CA) will report earnings on 2026-06-16, after the market close.
The consensus EPS estimate for the next earnings of AURORA CANNABIS INC (ACB.CA) is -0.05 CAD and the consensus revenue estimate is 82.05M CAD.
The number of analysts covering AURORA CANNABIS INC (ACB.CA) is 10.